Apixaban Cuts Stroke But Ups Bleeding in Subclinical AF
In patients with subclinical atrial fibrillation (AF) detected by implanted devices such as pacemakers or loop recorders, oral anticoagulation with apixaban resulted in a lower risk of stroke or systemic embolism than aspirin, but a higher risk of major bleeding in the ARTESIA study. The results appear to contrast somewhat with the recently reported NOAH-AFNET …